479690-08-9

Basic information

• Product Name: 7-Quinolinol, 4-(2-fluoro-4-nitrophenoxy)-6-methoxy-
• CAS NO: 479690-08-9
• Molecular Formula: C16H11FN2O5
• Molecular Weight: 330.272
• Mol File: 479690-08-9.mol
• Article Data: 11

Chemical Properties

• CAS DataBase Reference: 7-Quinolinol, 4-(2-fluoro-4-nitrophenoxy)-6-methoxy-(CAS DataBase Reference)
• NIST Chemistry Reference: 7-Quinolinol, 4-(2-fluoro-4-nitrophenoxy)-6-methoxy-(479690-08-9)
• EPA Substance Registry System: 7-Quinolinol, 4-(2-fluoro-4-nitrophenoxy)-6-methoxy-(479690-08-9)

Safety Data

• Hazardous Substances Data: 479690-08-9(Hazardous Substances Data)

Usage

General Description

7-Quinolinol, 4-(2-fluoro-4-nitrophenoxy)-6-methoxy- is a chemical compound with a quinolinol backbone, featuring a 4-(2-fluoro-4-nitrophenoxy)-6-methoxy substituent. It is a synthetic chemical that is used in various research and industrial applications. 7-Quinolinol, 4-(2-fluoro-4-nitrophenoxy)-6-methoxy- has been studied for its potential biological and pharmacological activities, including its role as a chelating agent and its potential antitumor and antiviral properties. The chemical structure of 7-Quinolinol, 4-(2-fluoro-4-nitrophenoxy)-6-methoxy- gives it unique properties and potential applications in various fields. However, like all chemicals, it should be handled and used with caution in laboratory and industrial settings.

Upstream product

• 516526-44-6 4-(2-fluoro-4-nitro-phenoxy)-6,7-dimethoxy-quinoline 
• 403-19-0 2-fluoro-4-nitrophenol 
• 636-93-1 5-nitroguaiacol 
• 61324-40-1 3-benzyloxy-4-methoxybenzeneamine 
• 75167-86-1 2-(benzyloxy)-1-methoxy-4-nitrobenzene 
• 205448-28-8 5-{[(3-(benzyloxy)-4-methoxyphenyl)amino]methylene}-2,2-dimethyl-1,3-dioxane-4,6- dione 
• 498-02-2 1-(3-methoxy-4-hydroxyphenyl)ethanone 
• 75665-88-2 1-(4-(benzyloxy)-5-methoxy-2-nitrophenyl)ethanone 
• 1835-11-6 4-benzyloxy-3-methoxyacetophenone 
• 479690-03-4 7-benzyloxy-4-(2-fluoro-4-nitro-phenoxy)-6-methyloxyquinoline 
• 205448-29-9 6-methoxy-7-benzyloxy-4(1H)-quinolinone 
• 75665-73-5 1-(2-amino-4-(benzyloxy)-5-methoxyphenyl)ethanone 

Downstream Products

• 479690-03-4 7-benzyloxy-4-(2-fluoro-4-nitro-phenoxy)-6-methyloxyquinoline 
• 516526-46-8 6-benzyloxy-4-(2-fluoro-4-nitrophenoxy)-7-methoxyquinoline 
• 849217-45-4 4-[4-(2-fluoro-4-nitro-phenoxy)-6-methoxy-quinolin-7-yloxymethyl]-piperidine-1-carboxylic acid tert-butyl ester 
• 1361031-47-1 {3-[4-(2-fluoro-4-nitrophenoxy)-6-methoxyquinolin-7-yloxy]propyl}carbamic acid tert-butyl ester 
• 1290538-60-1 {3-[4-(4-amino-2-fluorophenoxy)-6-methoxyquinolin-7-yloxy]propyl}carbamic acid tert-butyl ester 
• 960299-44-9 4-(3-((4-(2-fluoro-4-nitrophenoxy)-6-methoxyquinolin-7-yl)oxy)propyl)morpholine 
• 1436418-00-6 4-(2-fluoro-4-nitrophenoxy)-6-methoxy-7-(3-(piperidin-1-yl)propoxy)quinoline 
• 1436418-01-7 4-(2-fluoro-4-nitrophenoxy)-6-methoxy-7-(3-(4-methylpiperidin-1-yl)propoxy)quinoline 
• 1292258-07-1 3-fluoro-N-(3-fluoro-4-{6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinolin-4-yloxy}phenyl)benzenesulfonamide 
• 1292258-23-1 2-chloro-N-(3-fluoro-4-{6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinolin-4-yloxy}phenyl)benzenesulfonamide 
• 1292258-01-5 2,5-dichloro-N-(3-fluoro-4-{6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinolin-4-yloxy}phenyl)benzenesulfonamide 
• 1292258-27-5 2,6-dichloro-N-(3-fluoro-4-{6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinolin-4-yloxy}phenyl)benzenesulfonamide 
• 1292258-10-6 3-chloro-4-fluoro-N-(3-fluoro-4-{6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinolin-4-yloxy}phenyl)benzenesulfonamide 
• 1192300-04-1 N-{3-fluoro-4-[6-methoxy-7-(2-morpholin-4-ylethoxy)quinolin-4-yloxy]phenyl}-2-trifluoromethylbenzenesulfonamide 

Relevant articles and documents

Discovery of 4-((4-(4-(3-(2-(2,6-difluorophenyl)-4-oxothiazolidin-3-yl)ureido)-2-fluorophenoxy)-6-methoxyquinolin-7-yl)oxy)-N,N-diethylpiperidine-1-carboxamide as kinase inhibitor for the treatment of colorectal cancer

In this study, a novel series of 4,6,7-trisubstituted quinoline analogues bearing thiazolidinones were designed and synthesized based on our previous study. Among them, the most potent compound 15i, 4-((4-(4-(3-(2-(2,6-difluorophenyl)-4-oxothiazolidin-3-y

Preparation methods of tyrosine kinase inhibitor XJF007 and its intermediate

The invention discloses preparation methods of tyrosine kinase inhibitor XJF007 with a general structural formula (I) and its intermediate. The preparation method of the tyrosine kinase inhibitor XJF007 employs a collecting synthesis strategy of construct

Naphthyridine compound and pharmaceutical composition as well as applications thereof

The invention relates to the field of biological medicines and discloses a naphthyridine compound and a pharmaceutical composition as well as applications thereof. The naphthyridine compound has a structure shown in a formula (I) or a stereisomer, a geometric isomer, a tautomer, nitric oxide, hydrate, solvate, metabolite, a pharmaceutically acceptable salt or a prodrug. The naphthyridine compound disclosed by the invention has an anti-tumor effect which is obviously superior to the anti-tumor effect of the prior art. And moreover, the naphthyridine compound disclosed by the invention can treat diseases mediated by protein kinase.